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Abstract. 
According to the official annual report on the top 10 causes of death, cancer the leading 
cause of death in Taiwan in 2012, and among the leading causes of cancer death in 2011, hepa-
tocellular carcinoma was the second and gastric cancer the sixth. We report the case of a 
64-year-old male who was found to have primary gastric cancer and primary hepatocellular 
carcinoma synchronously. With regard to the strategies for dealing with double primary cancers, 
previous related reports and are review the prognosis. 
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中文摘要 
  根據 2012 年台灣年度十大死因報告，癌症仍然佔首位。而根據 2011 年的統計癌症死
亡中，不分性別，肝癌是第二常見死因，胃癌佔第六。我們報告一位 64 歲胃癌同時併發
肝癌之病人，並討論如何去診斷與證實兩者均為原發癌，回顧文獻，並探討無論是胃癌
併發肝癌或者肝癌併發胃癌之預後。 
 
關鍵字: 同時併發、胃癌、肝癌 
 
INTRODUCTION 
According to the official annual report on the top 
10 causes of death, cancer was the leading cause of 
death in Taiwan in 2012, and among the leading caus-
es of death in 2011, hepatocellular carcinoma was the 
second gastric cancer the sixth [1]. In our clinical 
practice, when a solitary hepatic tumor occurs syn-
chronously with gastric cancer, either the former or 
latter is usually presumed to be metastatic. But in viral 
hepatitis-endemic countries, such as Taiwan, double 
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 primary cancers should always be kept in mind in pa-
tients with gastric cancer concomitant with a solitary 
hepatic tumor in order to provide optimal treatment 
[2]. We report the case of a patient with gastric cancer 
synchronously associated with hepatocellular carci-
noma who was first treated surgically, followed by 
adjuvant concurrent chemo-radiation therapy (CCRT) 
for gastric cancer, and then with transarterial che-
moembolization (TACE) for hepatocellular carcino-
ma.  
 
CASE REPORT 
A 64-year-old male came to our gastrointestinal 
outpatient service for evaluation of intermittent epi-
gastralgia that began several weeks prior to this visit. 
The pain was relieved by meals and was dull in char-
acter. There was no acid regurgitation, dysphagia, easy 
satiety, loss of body weight, hematemesis or hemato-
chezia. He used to drink one glass of sorghum wine, 
which contained 28% alcohol, per day for 40 years. 
He had undergone appendectomy at his young age, 
and had no family history of malignancy. The blood 
pressure was 126/80 mmHg, the body temperature 36 
°C, pulse 78 beats per minute and respiration 18 times 
per minute. On physical examination, the positive 
finding was mild epigastric tenderness; there were no 
other abnormal findings such as spider angiomata or 
jaundice that are seen in liver cirrhosis.  
Laboratory data demonstrated hemoglobin of 14.9 
g/dL; leukocytes, 10600/uL, platelets, 256000/uL, and 
the prothrombin time International Normalized Ratio 
was 1.1. The results of biochemistry were as follows: 
ALT/AST 44/51 IU/L, total bilirubin 0.41 mg/dL, al-
bumin 3.5 g/dL, and r-GT 290 IU/L; the Child-Pugh  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. Panendoscopy disclosed an irregular gastric 
ulcerative tumor about 5 cm in size 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2. Microscopic finding of stomach lesions. 
Irregular nests of carcinoma cells in ne-
crotic debris, as well as in a limited region 
of the mucosal fragments (HE stain X200) 
 
 
score was calculated to show a total of 6 points and 
class A. As to viral markers, HBsAg was negative and 
anti-HCV antibodies negative. Tumor makers con-
sisted of alpha-fetoprotein 17.0 ng/mL and CA19-9 15 
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Figure 3. Abdominal ultrasound. Mild coarse parenchymatous change without significant change in liver size, but 
with a dull angle and irregular surface. There were at least 2 hypoechoic nodules 20 mm (A) and 36.9 
mm (B), in diameter, in the right posterior segments. Multiple subcentimeter hypoechoic nodules at the 
right lobe (C) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4. Abdominal CT with and without contrast. Pre-contrast sections (A). Hyper-
vacular nodules in the arterial phase (B, arrow) in S6-7 of the liver with early 
wash-out in the portal venous and delay phase (C, D, arrow). The largest one 
measured about 3.3x2.7 cm 
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Figure 5. Abdominal CT with and without contrast. (A) Irregular mucosa with contrast enhancement and wall 
thickening of the antrum of the stomach (arrow). The border between mucosa and submucosa was 
blurred. (B) Multiple small lymph nodes at the gastrohepatic and hepatoduodenal ligaments; the largest 
one measured about 0.9x0.7cm in size (arrow and arrowhead) 
 
 
u/mL. Pan-endoscopy disclosed a duodenal polyp and 
an irregular gastric ulcerative tumor about 5 cm in size, 
with an elevated margin at the antrum and lower body 
(Figure 1); no pictures of gastroesophageal varices 
and the rapid Helicobacter pylori urease test was neg-
ative; biopsy was done at the same time. The endo-
scopic stomach biopsy was positive for anti-AE1/AE3 
immunostain which can currently be used as a rea-
sonably effective "epithelial screen" in search for epi-
thelial differentiation, the biopsy also showed irregu-
lar nests of carcinoma cells in necrotic debris in a lim-
ited region of the mucosal fragments, and the lesions 
was microscopically diagnosed as poorly-differentiated 
adenocarcinoma (Figure 2). 
Abdominal ultrasound disclosed two hypoechoic 
nodules about 2 cm and 3.6 cm in size at S6-7 (Figure 
3), in the liver, which was normal in size, but with a 
dull angle and an irregular surface. Because of the pa-
tient’s alcohol drinking habits and the early liver cir-
rhosis pattern seen on the abdominal image, our gas-
trointestinal doctor arranged a triphasic abdominal CT 
because of suspicion of primary hepatic tumors, even 
though our first impression was gastric cancer with liv-
er metastases. Abdominal CT demonstrated in the arte-
rial phase hyper-enhanced nodules at S6-7 of the liver, 
with an early wash-out in the delay phase; the largest 
nodule was about 3.3x2.7 cm (Figure 4). The radio-
graphic impression was hepatocellular carcinoma or 
hypervascular metastasis. An irregular mucosa with 
contrast enhancement and wall thickening of the an-
trum of the stomach were also found, and the border 
between the mucosa and submucosa was blurred (Fig-
ure 5). By means of sono-guided liver biopsy liver tis-
sue was obtained, which showed histological features 
of a typical hepatocellular carcinoma: macrotrabecular 
and pseudoglandular patterns; no bile ducts were seen 
within the tumor area, CD34 immunostaining high-
lighted the presence of blood vessels. Hepatocellular 
carcinoma was then finally proved after the sono- 
guided liver biopsy (Figure 6). A bone scan ruled out 
bone metastases and celiac angiography revealed hy-
pervascular tumor stains on S6-7, corresponding to a 
perfusion defect on CT-portography (Figure 7). The 
clinical TNM staging of gastric cancer was cT3N2M0, 
stage IIIA, and that of hepatocellular carcinoma 
T2N0M0, AJCC 7th stage II, BCLC stage: B. 
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Figure 6. Microscopic findings of liver lesions. (A) Sheets of hepatocellular carcinoma with occasional macro-
trabecular and pseudoglandular patterns, no bile ducts were seen within the tumor area. (B) CD34 im-
munostaining highlighted the sinusoidal vessels 
 
 
All of the above findings were compatible with 
double primary malignancies, consisting of gastric 
cancer and hepatocellular carcinoma. Radical subtotal 
gastrectomy with B-II anastomosis (antecolic) was 
performed for gastric cancer. Surgical pathology dis-
closed regional lymph node metastases, tumor inva-
sion of the serosa and also perineural invasion, so the 
staging was shifted to stage IIIB, pT4aN2M0. There-
after, the patient received 5FU-based concurrent 
chemoradiation. He also underwent TACE twice for 
hepatocellular carcinoma, and radiofrequency ablation 
for recurrent and residual lesions during outpatient 
follow-up. The hepatocellular carcinoma recurred at 
an interval of six and twelve months after the primary 
diagnosis. There were no side effects or complications 
after TACE or radiofrequency ablation. The follow-up 
abdominal CT disclosed lipiodol retention at S6-7 and 
no definite recurrent tumor at three months after 
TACE. The serum CEA and Alpha-fetoprotein level 
was around 3-5 ng/ml and 20-35 ng/ml during the 
follow-up period. This patient is regularly followed 
and was still alive at the time was this writing, 24 
months after the primary diagnosis.  
 
DISCUSSION 
According to the official annual report on the top 
10 causes of death, cancer was still the leading cause 
of death in Taiwan in 2012. Among the causes of can-
cer death, hepatocellular carcinoma was the second 
and gastric cancer the sixth in 2011, according to the 
National Health Research Institutes of Taiwan [1]. 
In dealing with our patient, we found ourselves 
going through three interesting thinking processes that 
we would like to discuss. The first is that even though 
we already knew the current history of gastric cancer 
and that multiple liver tumors were found by imaging, 
why we would consider arranging a triphasic CT for 
staging of gastric cancer and possible liver metastases: 
The strongest reason was that our patient had an alco-
hol drinking habit and a picture of liver cirrhosis,  
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Figure 7. Celiac angiography. Tumor stains is hyper-
vascularity (arrow) on S6-7 corresponding 
to a perfusion defect on CT-portography 
 
 
which were risk factors of hepatocellular carcinoma. 
Therefore, our initial impression was double primary 
cancers consisting of gastric cancer and a liver malig-
nancy. The second is why we still considered arrang-
ing sono-guided liver biopsy for pathologically proven 
primary hepatocellular carcinoma even though we 
already diagnosed it by imaging according to AASLD 
guidelines [3], using criteria including tumor size 
greater than 2 cm, liver cirrhosis history, and typical 
radiology pictures using triphasic CT or dynamic MRI. 
The third is that the prognosis of early-stage gastric 
cancer patients with a synchronous second primary 
cancer was worse in the presence of a second primary 
cancer than with the gastric cancer only [4]. The most 
common cause of death in patients with hepatocellular 
carcinoma and gastric cancer is the recurrence of 
hepatocellular carcinoma [5]. So we tried our best to 
confirm that this patient had double primary cancers in 
order to improve the survival chances of the patient, 
even though the possibility of gastric cancer with liver 
metastases was present at the beginning.  
Reviewing the literature, we have found that the 
incidence of gastric cancer with a synchronous second 
primary cancer varies from 2.0 to 10.9% [6]. The most 
likely second primary cancer was colorectal cancer, 
followed by liver and kidney caner [4]. The incidence 
of a second primary cancer has been increasing more 
in males than in females, and tends to be higher in 
elderly patients [7]. The incidence of synchronous 
cancer in early-stage gastric cancer is higher than in 
the advanced stage [7]. Some studies have reported 
that synchronous occurrence of double cancers, in-
cluding gastric cancer, has no effect on postoperative 
survival in patients with hepatocellular carcinoma 
when a simultaneous resection is performed [8]. Ex-
trahepatic primary cancer had no adverse effect on 
either patient survival or disease-free survival after 
hepatic resection [5]. There was no statistically sig-
nificant difference in overall survival as compared to 
patients with hepatocellular carcinoma only, suggest-
ing that the association of other primary tumors with 
hepatocellular carcinoma does not confer a worse 
prognosis [9].  
In conclusion, we have reported the case of a pa-
tient with gastric cancer associated with synchronous 
hepatocellular carcinoma. The patient was surgically 
treated for gastric cancer followed by adjuvant con-
current chemoradiation, and for hepatocellular carci-
noma, with both medical and radiologic interventions. 
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